{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:24Z","timestamp":1787020764251,"version":"build-2736575974"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872772, 81960546, 81700169 and U1812403 and 21867009"],"award-info":[{"award-number":["81872772, 81960546, 81700169 and U1812403 and 21867009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Science and Technology Department","doi-asserted-by":"publisher","award":["QKHJC[2018]1409, QKHZC [2019]2762, QKHPTRC[2020]5008, QKHZC[2020]4Y203"],"award-info":[{"award-number":["QKHJC[2018]1409, QKHZC [2019]2762, QKHPTRC[2020]5008, QKHZC[2020]4Y203"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunotherapeutic treatments are gaining attention due to their effective anti-tumor response. Particularly, the revolution of immune checkpoint inhibitors (ICIs) produces promising outcomes for various cancer types. However, the usage of immunotherapy is limited due to its low response rate, suggesting that tumor cells escape the immune surveillance. Rapid advances in transcriptomic profiling have led to recognize immune-related long non-coding RNAs (LncRNAs), as regulators of immune cell-specific gene expression that mediates immune stimulatory as well as suppression of immune response, indicating LncRNAs as targets to improve the efficacy of immunotherapy against tumours. Moreover, the immune-related LncRNAs acting as epigenetic modifiers are also under deep investigation. Thus, herein, is a summarised knowledge of LncRNAs and their regulation in the adaptive and innate immune system, considering their importance in autophagy and predicting putative immunotherapeutic responses.<\/jats:p>","DOI":"10.1186\/s13046-021-01997-5","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T07:02:42Z","timestamp":1627110162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells"],"prefix":"10.1186","volume":"40","author":[{"given":"Krishnapriya M.","family":"Varier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemavathi","family":"Dhandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-581X","authenticated-orcid":false,"given":"Babu","family":"Gajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"key":"1997_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejca.2017.01.035","volume":"81","author":"LA Emens","year":"2017","unstructured":"Emens LA, Ascierto PA, Darcy PK, Demaria S, Eggermont AMM, et al. Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape. Eur J Cancer. 2017;81:116\u201329. https:\/\/doi.org\/10.1016\/j.ejca.2017.01.035.","journal-title":"Eur J Cancer"},{"key":"1997_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fphar.2018.00245","volume":"9","author":"K Nurgali","year":"2018","unstructured":"Nurgali K, Jagoe RT, Abalo R. Editorial: Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae? Front Pharmacol. 2018;9:245. https:\/\/doi.org\/10.3389\/fphar.2018.00245.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1997_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s40425-019-0594-0","volume":"7","author":"HL Kaufman","year":"2019","unstructured":"Kaufman HL, Atkins MB, Subedi P, Wu J, Chambers J, Joseph Mattingly T, et al. The promise of Immuno-oncology: implications for defining the value of cancer treatment. J Immunother Cancer. 2019;7(1):129. https:\/\/doi.org\/10.1186\/s40425-019-0594-0.","journal-title":"J Immunother Cancer"},{"issue":"14","key":"1997_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.21037\/atm.2016.04.01","volume":"4","author":"NE Papaioannou","year":"2016","unstructured":"Papaioannou NE, Beniata OV, Vitsos P, Tsitsilonis O, Samara P. Harnessing the immune system to improve cancer therapy. Ann Transl Med. 2016;4(14):261. https:\/\/doi.org\/10.21037\/atm.2016.04.01.","journal-title":"Ann Transl Med"},{"issue":"24","key":"1997_CR5","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.18632\/oncotarget.2998","volume":"5","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqu\u00e9 A, Senovilla L, Baracco EE, et al. Classification of current anticancer immunotherapies. Oncotarget. 2014;5(24):12472\u2013508. https:\/\/doi.org\/10.18632\/oncotarget.2998.","journal-title":"Oncotarget"},{"issue":"3","key":"1997_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.4049\/jimmunol.175.3.1373","volume":"175","author":"M Rossi","year":"2005","unstructured":"Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol. 2005;175(3):1373\u201381. https:\/\/doi.org\/10.4049\/jimmunol.175.3.1373.","journal-title":"J Immunol"},{"issue":"7","key":"1997_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","volume":"38","author":"J Zugazagoitia","year":"2016","unstructured":"Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current challenges in cancer treatment. Clin Ther. 2016;38(7):1551\u201366. https:\/\/doi.org\/10.1016\/j.clinthera.2016.03.026.","journal-title":"Clin Ther"},{"issue":"1","key":"1997_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12282-016-0688-1","volume":"24","author":"K Kakimi","year":"2017","unstructured":"Kakimi K, Karasaki T, Matsushita H, Sugie T. Advances in personalized cancer immunotherapy. Breast Cancer. 2017;24(1):16\u201324. https:\/\/doi.org\/10.1007\/s12282-016-0688-1.","journal-title":"Breast Cancer"},{"key":"1997_CR9","doi-asserted-by":"publisher","unstructured":"Sambi M, Bagheri L, Szewczuk MR. Current challenges in cancer immunotherapy: Multimodal approaches to improve efficacy and patient response rates. J Oncol. 2019;2019:4508794. https:\/\/doi.org\/10.1155\/2019\/4508794.","DOI":"10.1155\/2019\/4508794"},{"issue":"6","key":"1997_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff YR, Warner AB, Wolchok JD. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res. 2020;30(6):507\u201319. https:\/\/doi.org\/10.1038\/s41422-020-0337-2.","journal-title":"Cell Res"},{"issue":"7","key":"1997_CR11","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1073\/pnas.1919764117","volume":"117","author":"F Mpekris","year":"2020","unstructured":"Mpekris F, Voutouri C, Baish JW, Duda DG, Munn LL, Stylianopoulos T, et al. Combining microenvironment normalization strategies to improve cancer immunotherapy. Proc Natl Acad Sci U S A. 2020;117(7):3728\u201337. https:\/\/doi.org\/10.1073\/pnas.1919764117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1997_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1534\/genetics.112.146704","volume":"193","author":"JT Kung","year":"2013","unstructured":"Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651\u201369. https:\/\/doi.org\/10.1534\/genetics.112.146704.","journal-title":"Genetics."},{"issue":"1","key":"1997_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/1878-0261.12413","volume":"13","author":"N Denaro","year":"2019","unstructured":"Denaro N, Merlano MC, Lo NC. Long noncoding RNAs as regulators of cancer immunity. Mol Oncol. 2019;13(1):61\u201373. https:\/\/doi.org\/10.1002\/1878-0261.12413.","journal-title":"Mol Oncol"},{"issue":"7011","key":"1997_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/431915a","volume":"431","author":"LD Stein","year":"2004","unstructured":"Stein LD. Human genome: end of the beginning. Nature. 2004;431(7011):915\u20136. https:\/\/doi.org\/10.1038\/431915a.","journal-title":"Nature."},{"issue":"2","key":"1997_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.semcancer.2008.01.005","volume":"18","author":"E Sonkoly","year":"2008","unstructured":"Sonkoly E, St\u00e5hle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 2008;18(2):131\u201340. https:\/\/doi.org\/10.1016\/j.semcancer.2008.01.005.","journal-title":"Semin Cancer Biol"},{"key":"1997_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fgene.2014.00178","volume":"5","author":"HM Lee","year":"2014","unstructured":"Lee HM, Nguyen DT, Lu LF. Progress and challenge of microRNA research in immunity. Front Genet. 2014;5:178. https:\/\/doi.org\/10.3389\/fgene.2014.00178.","journal-title":"Front Genet"},{"issue":"2","key":"1997_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1997_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fonc.2020.00285","volume":"10","author":"P Connerty","year":"2020","unstructured":"Connerty P, Lock RB, de Bock CE. Long Non-coding RNAs: Major regulators of cell stress in cancer. Front Oncol. 2020;10:285. https:\/\/doi.org\/10.3389\/fonc.2020.00285.","journal-title":"Front Oncol"},{"issue":"5","key":"1997_CR19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2013.07.047","volume":"154","author":"AC Tuck","year":"2013","unstructured":"Tuck AC, Tollervey D. A transcriptome-wide atlas of RNP composition reveals diverse classes of mRNAs and lncRNAs. Cell. 2013;154(5):996\u20131009. https:\/\/doi.org\/10.1016\/j.cell.2013.07.047.","journal-title":"Cell."},{"issue":"2","key":"1997_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/ncrna4020013","volume":"4","author":"GA Cipolla","year":"2018","unstructured":"Cipolla GA, de Oliveira JC, Salviano-Silva A, Lobo-Alves SC, Lemos DS, Oliveira LC, et al. Long non-coding RNAs in multifactorial diseases: Another layer of complexity. noncoding RNA. 2018;4(2):13. https:\/\/doi.org\/10.3390\/ncrna4020013.","journal-title":"noncoding RNA"},{"issue":"6","key":"1997_CR21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular Mechanisms of Long Noncoding RNAs. Mol Cell. 2011;43(6):904\u201314 https:\/\/doi.org\/10.1016\/j.molcel.2011.08.018.","journal-title":"Mol Cell"},{"issue":"3","key":"1997_CR22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2850.","journal-title":"Cancer Res"},{"issue":"6","key":"1997_CR23","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1093\/nar\/gkz117","volume":"47","author":"D Qu","year":"2019","unstructured":"Qu D, Sun WW, Li L, Ma L, Sun L, Jin X, et al. Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter. Nucleic Acids Res. 2019;47(6):3013\u201327. https:\/\/doi.org\/10.1093\/nar\/gkz117.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1997_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2015.05.004","volume":"42","author":"AT Satpathy","year":"2015","unstructured":"Satpathy AT, Chang HY. Long noncoding RNA in hematopoiesis and immunity. Immunity. 2015;42(5):792\u2013804. https:\/\/doi.org\/10.1016\/j.immuni.2015.05.004.","journal-title":"Immunity."},{"issue":"2","key":"1997_CR25","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","volume":"125","author":"FA Bonilla","year":"2010","unstructured":"Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol. 2010;125(2):S33\u201340. https:\/\/doi.org\/10.1016\/j.jaci.2009.09.017.","journal-title":"J Allergy Clin Immunol"},{"key":"1997_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-0203-4_1","volume":"2097","author":"SG Katz","year":"2020","unstructured":"Katz SG, Rabinovich PM. T Cell Reprogramming Against Cancer. Methods Mol Biol. 2020;2097:3\u201344. https:\/\/doi.org\/10.1007\/978-1-0716-0203-4_1.","journal-title":"Methods Mol Biol"},{"issue":"22","key":"1997_CR27","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1158\/1078-0432.CCR-15-0685","volume":"21","author":"L Mart\u00ednez-Lostao","year":"2015","unstructured":"Mart\u00ednez-Lostao L, Anel A, Pardo J. How do cytotoxic lymphocytes kill cancer cells? Clin Cancer Res. 2015;21(22):5047\u201356. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0685.","journal-title":"Clin Cancer Res"},{"key":"1997_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fonc.2020.00048","volume":"10","author":"Y Luo","year":"2020","unstructured":"Luo Y, Yang J, Yu J, Liu X, Yu C, Hu J, et al. Long non-coding RNAs: Emerging roles in the immunosuppressive tumor microenvironment. Front Oncol. 2020;10:48. https:\/\/doi.org\/10.3389\/fonc.2020.00048.","journal-title":"Front Oncol"},{"issue":"1","key":"1997_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-020-01154-0","volume":"19","author":"L Zhang","year":"2020","unstructured":"Zhang L, Xu X, Su X. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application. Mol Cancer. 2020;19(1):48. https:\/\/doi.org\/10.1186\/s12943-020-01154-0.","journal-title":"Mol Cancer"},{"issue":"7","key":"1997_CR30","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.7314\/apjcp.2015.16.7.2851","volume":"16","author":"LJ Pan","year":"2015","unstructured":"Pan LJ, Zhong TF, Tang RX, Li P, Dang YW, Huang SN, et al. Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues. Asian Pac J Cancer Prev. 2015;16(7):2851\u20135. https:\/\/doi.org\/10.7314\/apjcp.2015.16.7.2851.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"1997_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12253-016-0172-4","volume":"23","author":"W Peng","year":"2017","unstructured":"Peng W, Wang Z, Fan H. LncRNA NEAT1 impacts cell proliferation and apoptosis of colorectal cancer via regulation of Akt signaling. Pathol Oncol Res. 2017;23(3):651\u20136. https:\/\/doi.org\/10.1007\/s12253-016-0172-4.","journal-title":"Pathol Oncol Res"},{"key":"1997_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2019.01.019","volume":"110","author":"K Yan","year":"2019","unstructured":"Yan K, Fu Y, Zhu N, Wang Z, Hong JL, Li Y, et al. Repression of lncRNA NEAT1 enhances the antitumor activity of CD8+T cells against hepatocellular carcinoma via regulating miR-155\/Tim-3. Int J Biochem Cell Biol. 2019;110:1\u20138. https:\/\/doi.org\/10.1016\/j.biocel.2019.01.019.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1997_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41419-018-0528-7","volume":"9","author":"J Ji","year":"2018","unstructured":"Ji J, Yin Y, Ju H, Xu X, Liu W, Fu Q, et al. Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC. Cell Death Dis. 2018;9(5):478. https:\/\/doi.org\/10.1038\/s41419-018-0528-7.","journal-title":"Cell Death Dis"},{"issue":"10","key":"1997_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41590-018-0207-y","volume":"19","author":"D Huang","year":"2018","unstructured":"Huang D, Chen J, Yang L, Ouyang Q, Li J, Lao L, et al. NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. Nat Immunol. 2018;19(10):1112\u201325. https:\/\/doi.org\/10.1038\/s41590-018-0207-y.","journal-title":"Nat Immunol"},{"issue":"10","key":"1997_CR35","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1128\/jvi.77.10.5632-5638.2003","volume":"77","author":"S Vigneau","year":"2003","unstructured":"Vigneau S, Rohrlich PS, Brahic M, Bureau JF. Tmevpg1, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon. J Virol. 2003;77(10):5632\u20138. https:\/\/doi.org\/10.1128\/jvi.77.10.5632-5638.2003.","journal-title":"J Virol"},{"issue":"8","key":"1997_CR36","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1401099","volume":"193","author":"SP Collier","year":"2014","unstructured":"Collier SP, Henderson MA, Tossberg JT, Aune TM. Regulation of the Th1 genomic locus from Ifng through Tmevpg1 by T-bet. J Immunol. 2014;193(8):3959\u201365. https:\/\/doi.org\/10.4049\/jimmunol.1401099.","journal-title":"J Immunol"},{"issue":"4","key":"1997_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.cell.2013.01.015","volume":"152","author":"JA Gomez","year":"2013","unstructured":"Gomez JA, Wapinski OL, Yang YW, Bureau JF, Gopinath S, Monack DM, et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-\u03b3 locus. Cell. 2013;152(4):743\u201354. https:\/\/doi.org\/10.1016\/j.cell.2013.01.015.","journal-title":"Cell."},{"issue":"2","key":"1997_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/cells9020269","volume":"9","author":"I Ahmad","year":"2020","unstructured":"Ahmad I, Valverde A, Ahmad F, Naqvi AR. Long noncoding RNA in myeloid and lymphoid cell differentiation, polarization and function. Cells. 2020;9(2):269. https:\/\/doi.org\/10.3390\/cells9020269.","journal-title":"Cells."},{"issue":"3","key":"1997_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/ni.3093","volume":"16","author":"V Ranzani","year":"2015","unstructured":"Ranzani V, Rossetti G, Panzeri I, Arrigoni A, Bonnal RJ, Curti S, et al. The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4. Nat Immunol. 2015;16(3):318\u201325. https:\/\/doi.org\/10.1038\/ni.3093.","journal-title":"Nat Immunol"},{"key":"1997_CR40","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.cellimm.2018.01.013","volume":"343","author":"G Badalamenti","year":"2019","unstructured":"Badalamenti G, Fanale D, Incorvaia L, Barraco N, List\u00ec A, Maragliano R, et al. Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? Cell Immunol. 2019;343:103753. https:\/\/doi.org\/10.1016\/j.cellimm.2018.01.013.","journal-title":"Cell Immunol"},{"key":"1997_CR41","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","volume":"35","author":"DS Vinay","year":"2015","unstructured":"Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, et al. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015;35:S185\u201398. https:\/\/doi.org\/10.1016\/j.semcancer.2015.03.004.","journal-title":"Semin Cancer Biol"},{"key":"1997_CR42","doi-asserted-by":"publisher","first-page":"15129","DOI":"10.1038\/ncomms15129","volume":"8","author":"R Jiang","year":"2017","unstructured":"Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie Y, et al. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017;8:15129. https:\/\/doi.org\/10.1038\/ncomms15129.","journal-title":"Nat Commun"},{"issue":"6","key":"1997_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm.4086","volume":"22","author":"T Saito","year":"2016","unstructured":"Saito T, Nishikawa H, Wada H, Nagano Y, Sugiyama D, Atarashi K, et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat Med. 2016;22(6):679\u201384. https:\/\/doi.org\/10.1038\/nm.4086.","journal-title":"Nat Med"},{"issue":"17","key":"1997_CR44","doi-asserted-by":"publisher","first-page":"E3472","DOI":"10.1073\/pnas.1700946114","volume":"114","author":"D Zemmour","year":"2017","unstructured":"Zemmour D, Pratama A, Loughhead SM, Mathis D, Benoist C. Flicr, a long noncoding RNA, modulates Foxp3 expression and autoimmunity. Proc Natl Acad Sci U S A. 2017;114(17):E3472\u201380. https:\/\/doi.org\/10.1073\/pnas.1700946114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt A","key":"1997_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijbiomac.2018.06.033","volume":"118","author":"X Pei","year":"2018","unstructured":"Pei X, Wang X, Li H. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448\/IDO. Int J Biol Macromol. 2018;118(Pt A):24\u201330. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.06.033.","journal-title":"Int J Biol Macromol"},{"key":"1997_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biopha.2016.02.036","volume":"80","author":"M Zhang","year":"2016","unstructured":"Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding F, et al. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis. Biomed Pharmacother. 2016;80:73\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2016.02.036.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1997_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1134\/S0006297917040046","volume":"82","author":"L Wang","year":"2017","unstructured":"Wang L, Ye S, Wang J, Gu Z, Zhang Y, Zhang C, et al. HuR stabilizes lnc-Sox5 mRNA to promote tongue carcinogenesis. Biochemistry (Mosc). 2017;82(4):438\u201345. https:\/\/doi.org\/10.1134\/S0006297917040046.","journal-title":"Biochemistry (Mosc)"},{"key":"1997_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.omtn.2019.05.030","volume":"17","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liao G, Bai J, Zhang X, Xu L, Deng C, et al. Identifying cancer driver lncRNAs bridged by functional effectors through integrating multi-omics data in human cancers. Mol Ther Nucleic Acids. 2019;17:362\u201373. https:\/\/doi.org\/10.1016\/j.omtn.2019.05.030.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"1997_CR49","doi-asserted-by":"publisher","first-page":"23176","DOI":"10.1002\/jcp.28884","volume":"234","author":"WY Zhou","year":"2019","unstructured":"Zhou WY, Zhang MM, Liu C, Kang Y, Wang JO, Yang XH. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p. J Cell Physiol. 2019;234(12):23176\u201389. https:\/\/doi.org\/10.1002\/jcp.28884.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1997_CR50","doi-asserted-by":"publisher","first-page":"14418","DOI":"10.1038\/s41598-018-32793-5","volume":"8","author":"H Kathuria","year":"2018","unstructured":"Kathuria H, Millien G, McNally L, Gower AC, Tagne JB, Cao Y, et al. NKX2-1-AS1 negatively regulates CD274\/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell migration. Sci Rep. 2018;8(1):14418. https:\/\/doi.org\/10.1038\/s41598-018-32793-5.","journal-title":"Sci Rep"},{"key":"1997_CR51","doi-asserted-by":"publisher","unstructured":"Zhang C, Jiang F, Su C, Xie P, Xu L. Upregulation of long noncoding RNA SNHG20 promotes cell growth and metastasis in esophageal squamous cell carcinoma via modulating ATM-JAK-PD-L1 pathway. J Cell Biochem. 2019. https:\/\/doi.org\/10.1002\/jcb.28444.","DOI":"10.1002\/jcb.28444"},{"issue":"10","key":"1997_CR52","doi-asserted-by":"publisher","first-page":"e0141042","DOI":"10.1371\/journal.pone.0141042","volume":"10","author":"J Zhang","year":"2015","unstructured":"Zhang J, Fan D, Jian Z, Chen GG, Lai PB. Cancer specific long noncoding RNAs show differential expression patterns and competing endogenous RNA potential in hepatocellular carcinoma. PLoS One. 2015;10(10):e0141042. https:\/\/doi.org\/10.1371\/journal.pone.0141042.","journal-title":"PLoS One"},{"issue":"6","key":"1997_CR53","doi-asserted-by":"publisher","first-page":"101042831770788","DOI":"10.1177\/1010428317707882","volume":"39","author":"K Yao","year":"2017","unstructured":"Yao K, Wang Q, Jia J, Zhao H. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer. Tumour Biol. 2017;39(6):1010428317707882. https:\/\/doi.org\/10.1177\/1010428317707882.","journal-title":"Tumour Biol"},{"issue":"10","key":"1997_CR54","doi-asserted-by":"publisher","first-page":"e0240321","DOI":"10.1371\/journal.pone.0240321","volume":"15","author":"X Liu","year":"2020","unstructured":"Liu X, Huang G, Zhang J, Zhang L, Liang Z. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis. PLoS One. 2020;15(10):e0240321. https:\/\/doi.org\/10.1371\/journal.pone.0240321.","journal-title":"PLoS One"},{"issue":"1748","key":"1997_CR55","doi-asserted-by":"publisher","first-page":"20170074","DOI":"10.1098\/rstb.2017.0074","volume":"373","author":"DJ Hanly","year":"2018","unstructured":"Hanly DJ, Esteller M, Berdasco M. Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer? Philos Trans R Soc Lond Ser B Biol Sci. 2018;373(1748):20170074. https:\/\/doi.org\/10.1098\/rstb.2017.0074.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"17","key":"1997_CR56","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/1873-3468.12315","volume":"590","author":"G Zhao","year":"2016","unstructured":"Zhao G, Su Z, Song D, Mao Y, Mao X. The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-\u03baB. FEBS Lett. 2016;590(17):2884\u201395. https:\/\/doi.org\/10.1002\/1873-3468.12315.","journal-title":"FEBS Lett"},{"key":"1997_CR57","doi-asserted-by":"publisher","first-page":"116335","DOI":"10.1016\/j.lfs.2019.03.040","volume":"231","author":"QM Wang","year":"2019","unstructured":"Wang QM, Lian GY, Song Y, Huang YF, Gong Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335. https:\/\/doi.org\/10.1016\/j.lfs.2019.03.040.","journal-title":"Life Sci"},{"issue":"12","key":"1997_CR58","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/eji.1830111203","volume":"11","author":"Y Ron","year":"1981","unstructured":"Ron Y, De Baetselier P, Gordon J, Feldman M, Segal S. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur J Immunol. 1981;11(12):964\u20138. https:\/\/doi.org\/10.1002\/eji.1830111203.","journal-title":"Eur J Immunol"},{"issue":"9","key":"1997_CR59","doi-asserted-by":"publisher","first-page":"e0138236","DOI":"10.1371\/journal.pone.0138236","volume":"10","author":"A Petri","year":"2015","unstructured":"Petri A, Dybk\u00e6r K, B\u00f8gsted M, Thrue CA, Hagedorn PH, Schmitz A, et al. Long noncoding RNA expression during human B-cell development. PLoS One. 2015;10(9):e0138236. https:\/\/doi.org\/10.1371\/journal.pone.0138236.","journal-title":"PLoS One"},{"issue":"12","key":"1997_CR60","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/leu.2014.126","volume":"28","author":"L Sehgal","year":"2014","unstructured":"Sehgal L, Mathur R, Braun FK, Wise JF, Berkova Z, Neelapu S, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 2014;28(12):2376\u201387. https:\/\/doi.org\/10.1038\/leu.2014.126.","journal-title":"Leukemia."},{"issue":"12","key":"1997_CR61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3760\/cma.j.issn.0376-2491.2016.12.009","volume":"96","author":"SW Zhou","year":"2016","unstructured":"Zhou SW, Su BB, Zhou Y. Expression of FAS-AS1 in breast cancer and its effect on the host gene sFas. Zhonghua Yi Xue Za Zhi. 2016;96(12):949\u201353. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2016.12.009.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"1997_CR62","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3892\/ol.2019.10414","volume":"18","author":"W Zhou","year":"2019","unstructured":"Zhou W, Liu T, Saren G, Liao L, Fang W, Zhao H. Comprehensive analysis of differentially expressed long non-coding RNAs in non-small cell lung cancer. Oncol Lett. 2019;18(2):1145\u201356. https:\/\/doi.org\/10.3892\/ol.2019.10414.","journal-title":"Oncol Lett"},{"issue":"1","key":"1997_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","volume":"17","author":"U Klein","year":"2010","unstructured":"Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, et al. The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell. 2010;17(1):28\u201340. https:\/\/doi.org\/10.1016\/j.ccr.2009.11.019.","journal-title":"Cancer Cell"},{"issue":"12","key":"1997_CR64","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10038-006-0070-9","volume":"51","author":"N Ishii","year":"2006","unstructured":"Ishii N, Ozaki K, Sato H, Mizuno H. Susumu Saito, Takahashi A, et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet. 2006;51(12):1087\u201399. https:\/\/doi.org\/10.1007\/s10038-006-0070-9.","journal-title":"J Hum Genet"},{"issue":"2","key":"1997_CR65","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1261\/rna.1441510","volume":"16","author":"J Sheik Mohamed","year":"2010","unstructured":"Sheik Mohamed J, Gaughwin PM, Lim B, Robson P, Lipovich L. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA. 2010;16(2):324\u201337. https:\/\/doi.org\/10.1261\/rna.1441510.","journal-title":"RNA."},{"issue":"34","key":"1997_CR66","doi-asserted-by":"publisher","first-page":"54174","DOI":"10.18632\/oncotarget.11099","volume":"7","author":"A Sattari","year":"2016","unstructured":"Sattari A, Siddiqui H, Moshiri F, Ngankeu A, Nakamura T, Kipps TJ, et al. Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias. Oncotarget. 2016;7(34):54174\u201382. https:\/\/doi.org\/10.18632\/oncotarget.11099.","journal-title":"Oncotarget"},{"issue":"50","key":"1997_CR67","doi-asserted-by":"publisher","first-page":"82400","DOI":"10.18632\/oncotarget.12252","volume":"7","author":"LQ Wang","year":"2016","unstructured":"Wang LQ, Wong KY, Li ZH, Chim CS. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia. Oncotarget. 2016;7(50):82400\u201310. https:\/\/doi.org\/10.18632\/oncotarget.12252.","journal-title":"Oncotarget"},{"issue":"7","key":"1997_CR68","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1038\/emm.2013.59","volume":"45","author":"SM Park","year":"2013","unstructured":"Park SM, Park SJ, Kim HJ, Kwon OH, Kang TW, Sohn HA, et al. A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis. Exp Mol Med. 2013;45(7):e31. https:\/\/doi.org\/10.1038\/emm.2013.59.","journal-title":"Exp Mol Med"},{"key":"1997_CR69","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/1471-2407-14-809","volume":"14","author":"SF Cho","year":"2014","unstructured":"Cho SF, Chang YC, Chang CS, Lin SF, Liu YC, Hsiao HH, et al. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer. 2014;14:809. https:\/\/doi.org\/10.1186\/1471-2407-14-809.","journal-title":"BMC Cancer"},{"issue":"4","key":"1997_CR70","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018;18(4):e27. https:\/\/doi.org\/10.4110\/in.2018.18.e27.","journal-title":"Immune Netw"},{"issue":"2","key":"1997_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1753425919827632","volume":"25","author":"P Fang","year":"2019","unstructured":"Fang P, Xiang L, Chen W, Li S, Huang S, Li J, et al. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544\/RUNX3. Innate Immun. 2019;25(2):99\u2013109. https:\/\/doi.org\/10.1177\/1753425919827632.","journal-title":"Innate Immun"},{"issue":"5","key":"1997_CR72","doi-asserted-by":"publisher","first-page":"101042831770164","DOI":"10.1177\/1010428317701648","volume":"39","author":"E Baytak","year":"2017","unstructured":"Baytak E, Gong Q, Akman B, Yuan H, Chan WC, K\u00fc\u00e7\u00fck C. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer\/T-cell lymphoma and establishes MIR155HG as a target of PRDM1. Tumour Biol. 2017;39(5):1010428317701648. https:\/\/doi.org\/10.1177\/1010428317701648.","journal-title":"Tumour Biol"},{"issue":"5","key":"1997_CR73","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1261\/rna.2528811","volume":"17","author":"ME Askarian-Amiri","year":"2011","unstructured":"Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, Clark MB, et al. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011;17(5):878\u201391. https:\/\/doi.org\/10.1261\/rna.2528811.","journal-title":"RNA."},{"key":"1997_CR74","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fonc.2019.00515","volume":"9","author":"M Mei","year":"2019","unstructured":"Mei M, Zhang M. Non-coding RNAs in natural killer\/T-cell lymphoma. Front Oncol. 2019;9:515. https:\/\/doi.org\/10.3389\/fonc.2019.00515.","journal-title":"Front Oncol"},{"issue":"8","key":"1997_CR75","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1002\/jcb.28529","volume":"120","author":"L Zhu","year":"2019","unstructured":"Zhu L, Zhang X, Fu X, Li Z, Sun Z, Wu J, et al. c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer\/T-cell lymphoma. J Cell Biochem. 2019;120(8):12628\u201337. https:\/\/doi.org\/10.1002\/jcb.28529.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1997_CR76","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3892\/ol.2018.9606","volume":"17","author":"Y Ma","year":"2019","unstructured":"Ma Y, Zhang C, Zhang B, Yu H, Yu Q. circRNA of AR-suppressed PABPC1 91 bp enhances the cytotoxicity of natural killer cells against hepatocellular carcinoma via upregulating UL16 binding protein 1. Oncol Lett. 2019;17(1):388\u201397. https:\/\/doi.org\/10.3892\/ol.2018.9606.","journal-title":"Oncol Lett"},{"issue":"1","key":"1997_CR77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41(1):21\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.013.","journal-title":"Immunity."},{"key":"1997_CR78","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D. From monocytes to M1\/M2 macrophages: Phenotypical vs. functional differentiation. Front Immunol. 2014;5:514. https:\/\/doi.org\/10.3389\/fimmu.2014.00514.","journal-title":"Front Immunol"},{"issue":"3","key":"1997_CR79","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/jcb.26509","volume":"119","author":"Y Ye","year":"2018","unstructured":"Ye Y, Xu Y, Lai Y, He W, Li Y, Wang R, et al. Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1\/M2 macrophage polarization. J Cell Biochem. 2018;119(3):2951\u201363. https:\/\/doi.org\/10.1002\/jcb.26509.","journal-title":"J Cell Biochem"},{"key":"1997_CR80","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3389\/fimmu.2018.01557","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Feng J, Fu H, Liu C, Yu Z, Sun Y, et al. Coagulation factor X regulated by CASC2c recruited macrophages and induced M2 polarization in glioblastoma multiforme. Front Immunol. 2018;9:1557. https:\/\/doi.org\/10.3389\/fimmu.2018.01557.","journal-title":"Front Immunol"},{"issue":"11","key":"1997_CR81","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41419-019-2077-0","volume":"10","author":"ZX Liang","year":"2019","unstructured":"Liang ZX, Liu HS, Wang FW, Xiong L, Zhou C, Hu T, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Dis. 2019;10(11):829. https:\/\/doi.org\/10.1038\/s41419-019-2077-0.","journal-title":"Cell Death Dis"},{"issue":"10","key":"1997_CR82","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/ijms19102958","volume":"19","author":"X Li","year":"2018","unstructured":"Li X, Lei Y, Wu M, Li N. Regulation of macrophage activation and polarization by HCC-derived exosomal lncRNA TUC339. Int J Mol Sci. 2018;19(10):2958. https:\/\/doi.org\/10.3390\/ijms19102958.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1997_CR83","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2326-6066.CIR-18-0145","volume":"7","author":"J Cao","year":"2019","unstructured":"Cao J, Dong R, Jiang L, Gong Y, Yuan M, You J, et al. LncRNA-MM2P identified as a modulator of macrophage M2 polarization. Cancer Immunol Res. 2019;7(2):292\u2013305. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0145.","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"1997_CR84","first-page":"9052","volume":"8","author":"S Chen","year":"2015","unstructured":"Chen S, Shao C, Xu M, Ji J, Xie Y, Lei Y, et al. Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1. Int J Clin Exp Pathol. 2015;8(8):9052\u201361.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1997_CR85","doi-asserted-by":"publisher","first-page":"e85841","DOI":"10.1172\/jci.insight.85841","volume":"1","author":"K Gabrusiewicz","year":"2016","unstructured":"Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, et al. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016;1(2):e85841. https:\/\/doi.org\/10.1172\/jci.insight.85841.","journal-title":"JCI Insight"},{"issue":"1","key":"1997_CR86","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1038\/s41467-018-06152-x","volume":"9","author":"C Chen","year":"2018","unstructured":"Chen C, He W, Huang J, Wang B, Li H, Cai Q, et al. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nat Commun. 2018;9(1):3826. https:\/\/doi.org\/10.1038\/s41467-018-06152-x.","journal-title":"Nat Commun"},{"key":"1997_CR87","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3389\/fimmu.2019.01734","volume":"10","author":"G Leija Montoya","year":"2019","unstructured":"Leija Montoya G, Gonz\u00e1lez Ram\u00edrez J, Sandoval Basilio J, Seraf\u00edn Higuera I, Isiordia Espinoza M, Gonz\u00e1lez Gonz\u00e1lez R, et al. Long non-coding RNAs: Regulators of the activity of myeloid-derived suppressor cells. Front Immunol. 2019;10:1734. https:\/\/doi.org\/10.3389\/fimmu.2019.01734.","journal-title":"Front Immunol"},{"issue":"1","key":"1997_CR88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/pros.23716","volume":"79","author":"J Liu","year":"2019","unstructured":"Liu J, Ding D, Jiang Z, Du T, Liu J, Kong Z. Long non-coding RNA CCAT1\/miR-148a\/PKC\u03b6 prevents cell migration of prostate cancer by altering macrophage polarization. Prostate. 2019;79(1):105\u201312. https:\/\/doi.org\/10.1002\/pros.23716.","journal-title":"Prostate."},{"key":"1997_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biocel.2018.08.017","volume":"104","author":"YX Zhou","year":"2018","unstructured":"Zhou YX, Zhao W, Mao LW, Wang YL, Xia LQ, Cao M, et al. Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a. Int J Biochem Cell Biol. 2018;104:25\u201333. https:\/\/doi.org\/10.1016\/j.biocel.2018.08.017.","journal-title":"Int J Biochem Cell Biol"},{"issue":"45","key":"1997_CR90","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1038\/s41388-018-0387-9","volume":"37","author":"F Kong","year":"2018","unstructured":"Kong F, Deng X, Kong X, Du Y, Li L, Zhu H, et al. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF. Oncogene. 2018;37(45):5982\u201396. https:\/\/doi.org\/10.1038\/s41388-018-0387-9.","journal-title":"Oncogene."},{"issue":"1","key":"1997_CR91","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1080\/21691401.2019.1687504","volume":"47","author":"M Rajabinejad","year":"2019","unstructured":"Rajabinejad M, Salari F, Gorgin Karaji A, Rezaiemanesh A. The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells? Artif Cells Nanomed Biotechnol. 2019;47(1):4149\u201358. https:\/\/doi.org\/10.1080\/21691401.2019.1687504.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"1997_CR92","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162\u201374. https:\/\/doi.org\/10.1038\/nri2506.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1997_CR93","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/cells9030561","volume":"9","author":"AMK Law","year":"2020","unstructured":"Law AMK, Valdes-Mora F, Gallego-Ortega D. Myeloid-derived suppressor cells as a therapeutic target for cancer. Cells. 2020;9(3):561. https:\/\/doi.org\/10.3390\/cells9030561.","journal-title":"Cells."},{"key":"1997_CR94","doi-asserted-by":"publisher","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021:1\u201314. https:\/\/doi.org\/10.1038\/s41577-020-00490-y.","DOI":"10.1038\/s41577-020-00490-y"},{"issue":"2","key":"1997_CR95","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1189\/jlb.5VMR1116-493R","volume":"102","author":"A Hatziioannou","year":"2017","unstructured":"Hatziioannou A, Alissafi T, Verginis P. Myeloid-derived suppressor cells and T regulatory cells in tumors: unraveling the dark side of the force. J Leukoc Biol. 2017;102(2):407\u201321. https:\/\/doi.org\/10.1189\/jlb.5VMR1116-493R.","journal-title":"J Leukoc Biol"},{"key":"1997_CR96","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3389\/fimmu.2019.01401","volume":"10","author":"P Ma","year":"2019","unstructured":"Ma P, Beatty PL, McKolanis J, Brand R, Schoen RE, Finn OJ. Circulating myeloid derived suppressor cells (MDSC) that Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer. Front Immunol. 2019;10:1401. https:\/\/doi.org\/10.3389\/fimmu.2019.01401.","journal-title":"Front Immunol"},{"issue":"5","key":"1997_CR97","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/2326-6066.CIR-18-0443","volume":"7","author":"W Shang","year":"2019","unstructured":"Shang W, Gao Y, Tang Z, Zhang Y, Yang R. The pseudogene\u00a0Olfr29-ps1\u00a0promotes the suppressive function and differentiation of monocytic MDSCs. Cancer Immunol Res. 2019;7(5):813\u201327. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0443.","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"1997_CR98","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.4049\/jimmunol.1701721","volume":"200","author":"Y Gao","year":"2018","unstructured":"Gao Y, Wang T, Li Y, Zhang Y, Yang R. Lnc-chop\u00a0promotes immunosuppressive function of myeloid-derived suppressor cells in tumor and inflammatory environments. J Immunol. 2018;200(8):2603\u201314. https:\/\/doi.org\/10.4049\/jimmunol.1701721.","journal-title":"J Immunol"},{"issue":"67","key":"1997_CR99","doi-asserted-by":"publisher","first-page":"111754","DOI":"10.18632\/oncotarget.22906","volume":"8","author":"W Shang","year":"2017","unstructured":"Shang W, Tang Z, Gao Y, Qi H, Su X, Zhang Y, et al. LncRNA RNCR3 promotes Chop expression by sponging miR-185-5p during MDSC differentiation. Oncotarget. 2017;8(67):111754\u201369. https:\/\/doi.org\/10.18632\/oncotarget.22906.","journal-title":"Oncotarget"},{"issue":"1","key":"1997_CR100","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12885-018-4564-6","volume":"18","author":"X Tian","year":"2018","unstructured":"Tian X, Ma J, Wang T, Tian J, Zheng Y, Peng R, et al. Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer. BMC Cancer. 2018;18(1):660. https:\/\/doi.org\/10.1186\/s12885-018-4564-6.","journal-title":"BMC Cancer"},{"issue":"1","key":"1997_CR101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-019-0978-2","volume":"18","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Tian X, Wang T, Xia X, Cao F, Tian J, et al. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Mol Cancer. 2019;18(1):61. https:\/\/doi.org\/10.1186\/s12943-019-0978-2.","journal-title":"Mol Cancer"},{"issue":"4","key":"1997_CR102","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1158\/2326-6066.CIR-19-0595","volume":"8","author":"X Tian","year":"2020","unstructured":"Tian X, Zheng Y, Yin K, Ma J, Tian J, Zhang Y, et al. LncRNA\u00a0AK036396\u00a0inhibits maturation and accelerates immunosuppression of polymorphonuclear myeloid-derived suppressor cells by enhancing the stability of Ficolin B. Cancer Immunol Res. 2020;8(4):565\u201377. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0595.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"1997_CR103","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728\u201341. https:\/\/doi.org\/10.1016\/j.cell.2011.10.026.","journal-title":"Cell."},{"issue":"4","key":"1997_CR104","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrmicro865","volume":"2","author":"K Kirkegaard","year":"2004","unstructured":"Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol. 2004;2(4):301\u201314. https:\/\/doi.org\/10.1038\/nrmicro865.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"1997_CR105","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/joim.12596","volume":"281","author":"R Nardacci","year":"2017","unstructured":"Nardacci R, Ciccosanti F, Marsella C, Ippolito G, Piacentini M, Fimia GM. Role of autophagy in HIV infection and pathogenesis. J Intern Med. 2017;281(5):422\u201332. https:\/\/doi.org\/10.1111\/joim.12596.","journal-title":"J Intern Med"},{"issue":"1","key":"1997_CR106","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-019-0944-z","volume":"18","author":"GM Jiang","year":"2019","unstructured":"Jiang GM, Tan Y, Wang H, Peng L, Chen HT, Meng XJ, et al. The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol Cancer. 2019;18(1):17. https:\/\/doi.org\/10.1186\/s12943-019-0944-z.","journal-title":"Mol Cancer"},{"key":"1997_CR107","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-981-15-0602-4_10","volume":"1206","author":"H Yao","year":"2019","unstructured":"Yao H, Han B, Zhang Y, Shen L, Huang R. Non-coding RNAs and Autophagy. Adv Exp Med Biol. 2019;1206:199\u2013220. https:\/\/doi.org\/10.1007\/978-981-15-0602-4_10.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"1997_CR108","doi-asserted-by":"publisher","first-page":"e3073","DOI":"10.1038\/cddis.2017.464","volume":"8","author":"L Yang","year":"2017","unstructured":"Yang L, Wang H, Shen Q, Feng L, Jin H. Long non-coding RNAs involved in autophagy regulation. Cell Death Dis. 2017;8(10):e3073. https:\/\/doi.org\/10.1038\/cddis.2017.464.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1997_CR109","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41418-018-0105-8","volume":"26","author":"Z Xue","year":"2019","unstructured":"Xue Z, Zhang Z, Liu H, Li W, Guo X, Zhang Z, et al. lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation. Cell Death Differ. 2019;26(1):130\u201345. https:\/\/doi.org\/10.1038\/s41418-018-0105-8.","journal-title":"Cell Death Differ"},{"key":"1997_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2017.04.017","volume":"354","author":"Z Li","year":"2017","unstructured":"Li Z, Li J, Tang N. Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation\/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression. Neuroscience. 2017;354:1\u201310. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.04.017.","journal-title":"Neuroscience."},{"key":"1997_CR111","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.2147\/CMAR.S169406","volume":"10","author":"ZX Li","year":"2018","unstructured":"Li ZX, Zhu QN, Zhang HB, Hu Y, Wang G, Zhu YS. MALAT1: a potential biomarker in cancer. Cancer Manag Res. 2018;10:6757\u201368. https:\/\/doi.org\/10.2147\/CMAR.S169406.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"1997_CR112","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bbrc.2017.08.070","volume":"492","author":"Z Fu","year":"2017","unstructured":"Fu Z, Luo W, Wang J, Peng T, Sun G, Shi J, et al. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma. Biochem Biophys Res Commun. 2017;492(3):480\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.070.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1997_CR113","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/cdd.2016.111","volume":"24","author":"ZH Chen","year":"2017","unstructured":"Chen ZH, Wang WT, Huang W, Fang K, Sun YM, Liu SR, et al. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Cell Death Differ. 2017;24(2):212\u201324. https:\/\/doi.org\/10.1038\/cdd.2016.111.","journal-title":"Cell Death Differ"},{"issue":"4","key":"1997_CR114","doi-asserted-by":"publisher","first-page":"e202149","DOI":"10.1001\/jamanetworkopen.2020.2149","volume":"3","author":"Y Yu","year":"2020","unstructured":"Yu Y, Zhang W, Li A, Chen Y, Ou Q, He Z, et al. Association of long noncoding RNA biomarkers with clinical immune subtype and prediction of immunotherapy response in patients with cancer. JAMA Netw Open. 2020;3(4):e202149. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2149.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1997_CR115","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bbrc.2015.07.040","volume":"464","author":"B Song","year":"2015","unstructured":"Song B, Guan Z, Liu F, Sun D, Wang K, Qu H. Long non-coding RNA HOTAIR promotes HLA-G expression via inhibiting miR-152 in gastric cancer cells. Biochem Biophys Res Commun. 2015;464(3):807\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.040.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1997_CR116","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/ijms20071637","volume":"20","author":"DF Osses","year":"2019","unstructured":"Osses DF, Roobol MJ, Schoots IG. Prediction medicine: Biomarkers, risk calculators and magnetic resonance imaging as risk stratification tools in prostate cancer diagnosis. Int J Mol Sci. 2019;20(7):1637. https:\/\/doi.org\/10.3390\/ijms20071637.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1997_CR117","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CCO.0000000000000065","volume":"26","author":"DA Sartori","year":"2014","unstructured":"Sartori DA, Chan DW. Biomarkers in prostate cancer: what\u2019s new? Curr Opin Oncol. 2014;26(3):259\u201364. https:\/\/doi.org\/10.1097\/CCO.0000000000000065.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"1997_CR118","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbrc.2017.06.055","volume":"490","author":"R Zhang","year":"2017","unstructured":"Zhang R, Xia Y, Wang Z, Zheng J, Chen Y, Li X, et al. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. Biochem Biophys Res Commun. 2017;490(2):406\u201314. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.055 Epub 2017 Jun 13. PMID: 28623135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1997_CR119","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13148-016-0274-6","volume":"8","author":"S Subhash","year":"2016","unstructured":"Subhash S, Andersson PO, Kosalai ST, Kanduri C, Kanduri M. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL. Clin Epigenetics. 2016;8:106. https:\/\/doi.org\/10.1186\/s13148-016-0274-6.","journal-title":"Clin Epigenetics"},{"issue":"14","key":"1997_CR120","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/onc.2014.131","volume":"34","author":"G Guo","year":"2015","unstructured":"Guo G, Kang Q, Zhu X, Chen Q, Wang X, Chen Y, et al. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA. Oncogene. 2015;34(14):1768\u201379. https:\/\/doi.org\/10.1038\/onc.2014.131.","journal-title":"Oncogene."},{"issue":"4","key":"1997_CR121","doi-asserted-by":"publisher","first-page":"330","DOI":"10.14348\/molcells.2016.2308","volume":"39","author":"L Chen","year":"2016","unstructured":"Chen L, Wang W, Cao L, Li Z, Wang X. Long non-coding RNA CCAT1 acts as a competing endogenous RNA to regulate cell growth and differentiation in acute myeloid leukemia. Mol Cell. 2016;39(4):330\u20136. https:\/\/doi.org\/10.14348\/molcells.2016.2308.","journal-title":"Mol Cell"},{"key":"1997_CR122","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-015-0364-7","volume":"14","author":"T Hirano","year":"2015","unstructured":"Hirano T, Yoshikawa R, Harada H, Harada Y, Ishida A, Yamazaki T. Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression. Mol Cancer. 2015;14:90. https:\/\/doi.org\/10.1186\/s12943-015-0364-7.","journal-title":"Mol Cancer"},{"issue":"5","key":"1997_CR123","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/138920211796429772","volume":"12","author":"XQ Wang","year":"2011","unstructured":"Wang XQ, Crutchley JL, Dostie J. Shaping the genome with non-coding RNAs. Curr Genomics. 2011;12(5):307\u201321. https:\/\/doi.org\/10.2174\/138920211796429772.","journal-title":"Curr Genomics"},{"issue":"17","key":"1997_CR124","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1016\/j.yexcr.2009.07.001","volume":"315","author":"M Lerner","year":"2009","unstructured":"Lerner M, Harada M, Lov\u00e9n J, Castro J, Davis Z, Oscier D, et al. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res. 2009;315(17):2941\u201352. https:\/\/doi.org\/10.1016\/j.yexcr.2009.07.001.","journal-title":"Exp Cell Res"},{"issue":"25","key":"1997_CR125","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1038\/onc.2013.291","volume":"33","author":"S Kasar","year":"2014","unstructured":"Kasar S, Underbayev C, Yuan Y, Hanlon M, Aly S, Khan H, et al. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a\/16-1 in chronic lymphocytic leukemia. Oncogene. 2014;33(25):3307\u201315. https:\/\/doi.org\/10.1038\/onc.2013.291.","journal-title":"Oncogene."},{"key":"1997_CR126","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1476-4598-13-123","volume":"13","author":"L Morenos","year":"2014","unstructured":"Morenos L, Chatterton Z, Ng JL, Halemba MS, Parkinson-Bates M, Mechinaud F, et al. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a\/16-1. Mol Cancer. 2014;13:123. https:\/\/doi.org\/10.1186\/1476-4598-13-123.","journal-title":"Mol Cancer"},{"issue":"3","key":"1997_CR127","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/10428190902763509","volume":"50","author":"D Mertens","year":"2009","unstructured":"Mertens D, Philippen A, Ruppel M, Allegra D, Bhattacharya N, Tschuch C, et al. Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk Lymphoma. 2009;50(3):502\u20135. https:\/\/doi.org\/10.1080\/10428190902763509.","journal-title":"Leuk Lymphoma"},{"key":"1997_CR128","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3389\/fimmu.2019.01121","volume":"10","author":"BG Barwick","year":"2019","unstructured":"Barwick BG, Gupta VA, Vertino PM, Boise LH. Cell of origin and genetic alterations in the pathogenesis of multiple myeloma. Front Immunol. 2019;10:1121. https:\/\/doi.org\/10.3389\/fimmu.2019.01121.","journal-title":"Front Immunol"},{"issue":"9","key":"1997_CR129","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1101\/gr.078378.108","volume":"18","author":"ME Dinger","year":"2008","unstructured":"Dinger ME, Amaral PP, Mercer TR, Pang KC, Bruce SJ, Gardiner BB, et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008;18(9):1433\u201345. https:\/\/doi.org\/10.1101\/gr.078378.108.","journal-title":"Genome Res"},{"issue":"2","key":"1997_CR130","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/onc.2008.373","volume":"28","author":"M Mourtada-Maarabouni","year":"2009","unstructured":"Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28(2):195\u2013208. https:\/\/doi.org\/10.1038\/onc.2008.373.","journal-title":"Oncogene."},{"issue":"2","key":"1997_CR131","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cancergencyto.2008.01.013","volume":"182","author":"Y Nakamura","year":"2008","unstructured":"Nakamura Y, Takahashi N, Kakegawa E, Yoshida K, Ito Y, Kayano H, et al. The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer Genet Cytogenet. 2008;182(2):144\u20139. https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.01.013 PMID: 18406879.","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"1997_CR132","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.clml.2014.02.011","volume":"14","author":"M Mourtada-Maarabouni","year":"2014","unstructured":"Mourtada-Maarabouni M, Williams GT. Role of GAS5 noncoding RNA in mediating the effects of rapamycin and its analogues on mantle cell lymphoma cells. Clin Lymphoma Myeloma Leuk. 2014;14(6):468\u201373. https:\/\/doi.org\/10.1016\/j.clml.2014.02.011 Epub 2014 Mar 3. PMID: 24703244.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"1997_CR133","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.3892\/or.2016.5147","volume":"36","author":"YY Zhang","year":"2016","unstructured":"Zhang YY, Huang SH, Zhou HR, Chen CJ, Tian LH, Shen JZ. Role of HOTAIR in the diagnosis and prognosis of acute leukemia. Oncol Rep. 2016;36(6):3113\u201322. https:\/\/doi.org\/10.3892\/or.2016.5147.","journal-title":"Oncol Rep"},{"issue":"5","key":"1997_CR134","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4132\/jptm.2016.06.06","volume":"50","author":"EJ Oh","year":"2016","unstructured":"Oh EJ, Kim SH, Yang WI, Ko YH, Yoon SO. Long non-coding RNA HOTAIR expression in diffuse large B-cell lymphoma: In relation to polycomb repressive complex pathway proteins and H3K27 trimethylation. J Pathol Transl Med. 2016;50(5):369\u201376. https:\/\/doi.org\/10.4132\/jptm.2016.06.06.","journal-title":"J Pathol Transl Med"},{"issue":"6","key":"1997_CR135","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.3892\/mmr.2016.5190","volume":"13","author":"Y Yan","year":"2016","unstructured":"Yan Y, Han J, Li Z, Yang H, Sui Y, Wang M. Elevated RNA expression of long non\u2011coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma. Mol Med Rep. 2016;13(6):5125\u201331. https:\/\/doi.org\/10.3892\/mmr.2016.5190.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1997_CR136","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/nar\/gkw966","volume":"45","author":"XQ Wang","year":"2017","unstructured":"Wang XQ, Dostie J. Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation. Nucleic Acids Res. 2017;45(3):1091\u2013104. https:\/\/doi.org\/10.1093\/nar\/gkw966.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"1997_CR137","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/jcb.24586","volume":"114","author":"H Zhao","year":"2013","unstructured":"Zhao H, Zhang X, Fraz\u00e3o JB, Condino-Neto A, Newburger PE. HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells. J Cell Biochem. 2013;114(10):2375\u201383. https:\/\/doi.org\/10.1002\/jcb.24586.","journal-title":"J Cell Biochem"},{"key":"1997_CR138","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.biopha.2016.02.032","volume":"79","author":"W Peng","year":"2016","unstructured":"Peng W, Wu J, Feng J. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma. Biomed Pharmacother. 2016;79:188\u201393. https:\/\/doi.org\/10.1016\/j.biopha.2016.02.032.","journal-title":"Biomed Pharmacother"},{"issue":"37","key":"1997_CR139","doi-asserted-by":"publisher","first-page":"60155","DOI":"10.18632\/oncotarget.11165","volume":"7","author":"A Mangiavacchi","year":"2016","unstructured":"Mangiavacchi A, Sorci M, Masciarelli S, Larivera S, Legnini I, Iosue I, et al. The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA. Oncotarget. 2016;7(37):60155\u201368. https:\/\/doi.org\/10.18632\/oncotarget.11165.","journal-title":"Oncotarget"},{"issue":"45","key":"1997_CR140","doi-asserted-by":"publisher","first-page":"73769","DOI":"10.18632\/oncotarget.12063","volume":"7","author":"F Ghazavi","year":"2016","unstructured":"Ghazavi F, De Moerloose B, Van Loocke W, Wallaert A, Helsmoortel HH, Ferster A, et al. Unique long non-coding RNA expression signature in ETV6\/RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Oncotarget. 2016;7(45):73769\u201380. https:\/\/doi.org\/10.18632\/oncotarget.12063.","journal-title":"Oncotarget"},{"issue":"8","key":"1997_CR141","doi-asserted-by":"publisher","first-page":"e105382","DOI":"10.1371\/journal.pone.0105382","volume":"9","author":"L Conde","year":"2014","unstructured":"Conde L, Riby J, Zhang J, Bracci PM, Skibola CF. Copy number variation analysis on a non-Hodgkin lymphoma case-control study identifies an 11q25 duplication associated with diffuse large B-cell lymphoma. PLoS One. 2014;9(8):e105382. https:\/\/doi.org\/10.1371\/journal.pone.0105382.","journal-title":"PLoS One"},{"issue":"3","key":"1997_CR142","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cell.2014.05.049","volume":"158","author":"T Trimarchi","year":"2014","unstructured":"Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla-Favera R, Tsirigos A, et al. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell. 2014;158(3):593\u2013606. https:\/\/doi.org\/10.1016\/j.cell.2014.05.049.","journal-title":"Cell."},{"key":"1997_CR143","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biopha.2015.12.001","volume":"77","author":"W Peng","year":"2016","unstructured":"Peng W, Feng J. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma. Biomed Pharmacother. 2016;77:65\u201371. https:\/\/doi.org\/10.1016\/j.biopha.2015.12.001.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1997_CR144","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.leukres.2009.06.019","volume":"34","author":"L Benetatos","year":"2010","unstructured":"Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M, et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res. 2010;34(2):148\u201353. https:\/\/doi.org\/10.1016\/j.leukres.2009.06.019.","journal-title":"Leuk Res"},{"issue":"11","key":"1997_CR145","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1210\/jc.2003-030222","volume":"88","author":"X Zhang","year":"2003","unstructured":"Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88(11):5119\u201326. https:\/\/doi.org\/10.1210\/jc.2003-030222.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1997_CR146","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/stem.1989","volume":"33","author":"W Zhuang","year":"2015","unstructured":"Zhuang W, Ge X, Yang S, Huang M, Zhuang W, Chen P, et al. Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription. Stem Cells. 2015;33(6):1985\u201397. https:\/\/doi.org\/10.1002\/stem.1989.","journal-title":"Stem Cells"},{"issue":"38","key":"1997_CR147","doi-asserted-by":"publisher","first-page":"E5261","DOI":"10.1073\/pnas.1505753112","volume":"112","author":"G Doose","year":"2015","unstructured":"Doose G, Haake A, Bernhart SH, L\u00f3pez C, Duggimpudi S, Wojciech F, et al. MINCR is a MYC-induced lncRNA able to modulate MYC\u2019s transcriptional network in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 2015;112(38):E5261\u201370. https:\/\/doi.org\/10.1073\/pnas.1505753112.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1997_CR148","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1476-4598-13-171","volume":"13","author":"S Emmrich","year":"2014","unstructured":"Emmrich S, Streltsov A, Schmidt F, Thangapandi VR, Reinhardt D, Klusmann JH. LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia. Mol Cancer. 2014;13:171. https:\/\/doi.org\/10.1186\/1476-4598-13-171.","journal-title":"Mol Cancer"},{"key":"1997_CR149","doi-asserted-by":"publisher","first-page":"13749","DOI":"10.1038\/srep13749","volume":"5","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wu P, Lin R, Rong L, Xue Y, Fang Y. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015;5:13749. https:\/\/doi.org\/10.1038\/srep13749.","journal-title":"Sci Rep"},{"issue":"2","key":"1997_CR150","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3892\/ol.2016.4738","volume":"12","author":"C Gao","year":"2016","unstructured":"Gao C, Zhang J, Wang Q, Ren C. Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemia. Oncol Lett. 2016;12(2):1051\u20137. https:\/\/doi.org\/10.3892\/ol.2016.4738.","journal-title":"Oncol Lett"},{"key":"1997_CR151","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-015-0223-4","volume":"8","author":"C Zeng","year":"2015","unstructured":"Zeng C, Yu X, Lai J, Yang L, Chen S, Li Y. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. J Hematol Oncol. 2015;8:126. https:\/\/doi.org\/10.1186\/s13045-015-0223-4.","journal-title":"J Hematol Oncol"},{"issue":"19","key":"1997_CR152","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1158\/0008-5472.CAN-12-0213","volume":"72","author":"H Nagoshi","year":"2012","unstructured":"Nagoshi H, Taki T, Hanamura I, Nitta M, Otsuki T, Nishida K, et al. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Cancer Res. 2012;72(19):4954\u201362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0213.","journal-title":"Cancer Res"},{"issue":"2","key":"1997_CR153","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/jcp.21133","volume":"213","author":"L Carramusa","year":"2007","unstructured":"Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, et al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol. 2007;213(2):511\u20138. https:\/\/doi.org\/10.1002\/jcp.21133.","journal-title":"J Cell Physiol"},{"issue":"12","key":"1997_CR154","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ng.696","volume":"42","author":"V Enciso-Mora","year":"2010","unstructured":"Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet. 2010;42(12):1126\u201330. https:\/\/doi.org\/10.1038\/ng.696.","journal-title":"Nat Genet"},{"issue":"11","key":"1997_CR155","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/j.1460-2075.1986.tb04578.x","volume":"5","author":"M Graham","year":"1986","unstructured":"Graham M, Adams JM. Chromosome 8 breakpoint far 3\u2019 of the c-myc oncogene in a Burkitt\u2019s lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. EMBO J. 1986;5(11):2845\u201351.","journal-title":"EMBO J"},{"issue":"9","key":"1997_CR156","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1073\/pnas.86.9.3257","volume":"86","author":"E Shtivelman","year":"1989","unstructured":"Shtivelman E, Henglein B, Groitl P, Lipp M, Bishop JM. Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1989;86(9):3257\u201360. https:\/\/doi.org\/10.1073\/pnas.86.9.3257.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1997_CR157","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.3109\/10428194.2013.790543","volume":"54","author":"Y Tsutsumi","year":"2013","unstructured":"Tsutsumi Y, Chinen Y, Sakamoto N, Nagoshi H, Nishida K, Kobayashi S, et al. Deletion or methylation of CDKN2A\/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality. Leuk Lymphoma. 2013;54(12):2760\u20134. https:\/\/doi.org\/10.3109\/10428194.2013.790543.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1997_CR158","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1365-2443.2000.00325.x","volume":"5","author":"R Tanaka","year":"2000","unstructured":"Tanaka R, Satoh H, Moriyama M, Satoh K, Morishita Y, Yoshida S, et al. Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells. 2000;5(4):277\u201387. https:\/\/doi.org\/10.1046\/j.1365-2443.2000.00325.x.","journal-title":"Genes Cells"},{"issue":"6","key":"1997_CR159","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3109\/10428194.2013.829574","volume":"55","author":"L Zhang","year":"2014","unstructured":"Zhang L, Xu HG, Lu C. A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells. Leuk Lymphoma. 2014;55(6):1373\u201382. https:\/\/doi.org\/10.3109\/10428194.2013.829574.","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"1997_CR160","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1038\/sj.onc.1203604","volume":"19","author":"M Saitou","year":"2000","unstructured":"Saitou M, Sugimoto J, Hatakeyama T, Russo G, Isobe M. Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene. 2000;19(23):2796\u2013802. https:\/\/doi.org\/10.1038\/sj.onc.1203604.","journal-title":"Oncogene."},{"key":"1997_CR161","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12943-015-0444-8","volume":"14","author":"KY Wong","year":"2015","unstructured":"Wong KY, Li Z, Zhang X, Leung GK, Chan GC, Chim CS. Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma. Mol Cancer. 2015;14:175. https:\/\/doi.org\/10.1186\/s12943-015-0444-8.","journal-title":"Mol Cancer"},{"issue":"10","key":"1997_CR162","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cancergen.2015.07.006","volume":"208","author":"N Coccaro","year":"2015","unstructured":"Coccaro N, Zagaria A, Tota G, Anelli L, Orsini P, Casieri P, et al. Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion\/duplication of chromosome 3. Cancer Genet. 2015;208(10):517\u201322. https:\/\/doi.org\/10.1016\/j.cancergen.2015.07.006.","journal-title":"Cancer Genet"},{"issue":"21","key":"1997_CR163","doi-asserted-by":"publisher","first-page":"18534","DOI":"10.18632\/oncotarget.4069","volume":"6","author":"JM Hughes","year":"2015","unstructured":"Hughes JM, Legnini I, Salvatori B, Masciarelli S, Marchioni M, Fazi F, et al. C\/EBP\u03b1-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget. 2015;6(21):18534\u201344. https:\/\/doi.org\/10.18632\/oncotarget.4069.","journal-title":"Oncotarget"},{"issue":"20","key":"1997_CR164","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/sj.onc.1202651","volume":"18","author":"C Plass","year":"1999","unstructured":"Plass C, Yu F, Yu L, Strout MP, El-Rifai W, Elonen E, et al. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene. 1999;18(20):3159\u201365. https:\/\/doi.org\/10.1038\/sj.onc.1202651.","journal-title":"Oncogene."},{"issue":"12","key":"1997_CR165","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1261\/rna.562907","volume":"13","author":"AR Dallosso","year":"2007","unstructured":"Dallosso AR, Hancock AL, Malik S, Salpekar A, King-Underwood L, Pritchard-Jones K, et al. Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA. 2007;13(12):2287\u201399. https:\/\/doi.org\/10.1261\/rna.562907.","journal-title":"RNA."},{"key":"1997_CR166","doi-asserted-by":"publisher","unstructured":"Zeng MN, Ma WL. Zheng WL, Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia. 2016;37(7):585\u201390. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2016.07.009.","DOI":"10.3760\/cma.j.issn.0253-2727.2016.07.009"},{"key":"1997_CR167","unstructured":"The LncRNA and Disease Database. http:\/\/www.cuilab.cn\/lncrnadisease."}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-01997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-021-01997-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-01997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T07:02:49Z","timestamp":1627110169000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-021-01997-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1186\/s13046-021-01997-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,24]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}